Dynamics of proinflammatory and anti-inflammatory cytokines in blood plasma in the treatment of back pain with non-steroidal anti-inflammatory drugs

Authors

DOI:

https://doi.org/10.15587/2519-4798.2019.185451

Keywords:

nonspecific back pain, cytokines, as markers of inflammation, non-steroidal anti-inflammatory drugs, visual analogue scale

Abstract

The objectification of non-specific back pain is still limited by subjective methods - interviewing the patient, using pain scales. In some cases, degenerative-dystrophic changes in the spine, increased muscle tone of the back are determined, but morphological changes in the spine do not always correlate with the presence and severity of pain. Therefore, the search for biomarkers that objectify the presence of pain, its intensity, would help in the differential diagnosis and in the treatment of pain, is relevant.

The aim: to search for biomarkers to objectify the presence of pain and facilitate the differential diagnosis and further treatment.

Materials and methods: 20 patients were studied - 14 women and 6 men - with vertebrogenic dorsalgia. For all patients, a standard vertebral neurological examination was performed using neuroimaging methods (radiography, MRI or CT of the spine). All patients were prescribed NSAID treatment in the same way: in the first two days, ketorolac was prescribed, then meloxicam or celecoxib, depending on the patients' comorbid pathology, during the 10 days of hospital stay, and then another 10 days for outpatient use. On days 1 and 10, we evaluated the intensity of the pain syndrome using a visual analogue scale (VAS). In parallel, in those days we took blood tests from all patients to measure the levels of cytokines - interleukin 1 β (IL-1β), interleukin 6 (IL-6), interleukin 10 (IL-10). We determined the level of pro-inflammatory (interleukin -1β, IL -1β, interleukin -6-IL-6) and anti-inflammatory cytokines (interleukin-10, IL -6) blood enzyme-linked immunosorbent assays using kits of the company "Vector Best" in the clinical laboratory of the "Institute of neurosurgery named after academician A.P. Romodanova NAMS of Ukraine". The indicators were expressed in conditional units (cu).

The results revealed a reliable direct correlation between the change in the intensity of the pain syndrome with dorsalgia and the levels of pro-inflammatory interleukins IL-1β, and the coefficient of IL-6 / IL-10. A reliable correlation of long-term pain indicators with a change in blood levels of IL-6 / IL-10 cytokines in the blood during the first days of NSAID treatment was first revealed.

Conclusions: according to the study, the level of pain with dorsalgia of various localization correlates with changes in the pro-inflammatory cytokines of IL-1β. A change in the ratio of pro-inflammatory and anti-inflammatory cytokines (IL6 / IL-10) correlates with a change in pain intensity. The level and rate of change of the IL6 / IL-10 coefficient are markers of the severity of the inflammatory process and reflect the likelihood of chronic pain in the future

Author Biographies

Iryna Maslova, Shupyk National Medical Academy of Postgraduate Education Dorohozhytska str., 9, Kyiv, Ukraine, 04112

Postgraduate Student

Department of Neurology No. 1

Tatyana Slobodin, Shupyk National Medical Academy of Postgraduate Education Dorohozhytska str., 9, Kyiv, Ukraine, 04112

MD, Professor

Department of Neurology No. 1

Natalia Mykhailovska, Shupyk National Medical Academy of Postgraduate Education Dorohozhytska str., 9, Kyiv, Ukraine, 04112

Postgraduate Student

Department of Neurology No. 1

Nikolay Lisyanyi, State Institution “Romodanov Neurosurgery Institute National Academy of Medical Science of Ukraine” Maiborody str., 32, Kyiv, Ukraine, 04050

MD, Professor, Corresponding Member of NAMS of Ukraine, Head of Department

Department of Neuroimmunology

References

  1. De Queiroz, B. Z., Pereira, D. S., Lopes, R. A., Felício, D. C., Silva, J. P., de Britto Rosa, N. M. et. al. (2016). Association Between the Plasma Levels of Mediators of Inflammation With Pain and Disability in the Elderly With Acute Low Back Pain. Spine, 41 (3), 197–203. doi: http://doi.org/10.1097/brs.0000000000001214
  2. Wang, K., Bao, J.-P., Yang, S., Hong, X., Liu, L., Xie, X.-H., Wu, X.-T. (2015). A cohort study comparing the serum levels of pro- or anti-inflammatory cytokines in patients with lumbar radicular pain and healthy subjects. European Spine Journal, 25 (5), 1428–1434. doi: http://doi.org/10.1007/s00586-015-4349-4
  3. Uceyler, N., Rogausch, J. P., Toyka, K. V., Sommer, C. (2007). Differential expression of cytokines in painful and painless neuropathies. Neurology, 69 (1), 42–49. doi: http://doi.org/10.1212/01.wnl.0000265062.92340.a5
  4. Zu, B., Pan, H., Zhang, X.-J., Yin, Z.-S. (2016). Serum Levels of the Inflammatory Cytokines in Patients with Lumbar Radicular Pain Due to Disc Herniation. Asian Spine Journal, 10 (5), 843–849. doi: http://doi.org/10.4184/asj.2016.10.5.843
  5. Kraychete, D. C., Sakata, R. K., Issy, A. M., Bacellar, O., Santos-Jesus, R., Carvalho, E. M. (2010). Serum cytokine levels in patients with chronic low back pain due to herniated disc: analytical cross-sectional study. Sao Paulo Medical Journal, 128 (5), 259–262. doi: http://doi.org/10.1590/s1516-31802010000500003
  6. Xue, H., Yaoet, Y., Wang, X., Zhang, F., Jiang, X., Liu, J. et. al. (2015). Interleukin-21 is associated with the pathogenesis of lumbar disc herniation. Iranian Journal of Allergy, Asthma and Immunology, 14, 509–518.
  7. Ye, S., Ju, B., Wang, H., Lee, K.-B. (2016). Bone morphogenetic protein-2 provokes interleukin-18-induced human intervertebral disc degeneration. Bone & Joint Research, 5 (9), 412–418. doi: http://doi.org/10.1302/2046-3758.59.bjr-2016-0032.r1
  8. Deng, X., Zhao, F., Kang, B., Zhang, X. (2016). Elevated interleukin-6 expression levels are associated with intervertebral disc degeneration. Experimental and Therapeutic Medicine, 11 (4), 1425–1432. doi: http://doi.org/10.3892/etm.2016.3079
  9. Risbud, M. V., Shapiro, I. M. (2013). Role of cytokines in intervertebral disc degeneration: pain and disc content. Nature Reviews Rheumatology, 10 (1), 44–56. doi: http://doi.org/10.1038/nrrheum.2013.160
  10. Shamji, M. F., Setton, L. A., Jarvis, W., So, S., Chen, J., Jing, L. et. al. (2010). Pro-inflammatory cytokine expression profile in degenerative and herniated human intervertebral disc tissues. Arthritis & Rheumatism, NA–NA. doi: http://doi.org/10.1002/art.30139

Downloads

Published

2019-12-11

How to Cite

Maslova, I., Slobodin, T., Mykhailovska, N., & Lisyanyi, N. (2019). Dynamics of proinflammatory and anti-inflammatory cytokines in blood plasma in the treatment of back pain with non-steroidal anti-inflammatory drugs. ScienceRise: Medical Science, (6 (33), 32–36. https://doi.org/10.15587/2519-4798.2019.185451

Issue

No. 6 (33) (2019)

Section

Medical Science

License

Copyright (c) 2019 Iryna Maslova, Tatyana Slobodin, Natalia Mykhailovska, Nikolay Lisyanyi

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.

Authors, who are published in this journal, agree to the following conditions:

1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons CC BY, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.

 2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.